strain
mice
inocul
intraperiton
denatur
mous
hepat
viru
strain
particl
viru
surfac
project
membran
ribonucleoprotein
subeompon
obtain
deterg
treat
purifi
viru
prepar
immunis
anim
develop
high
level
serum
antibodi
direct
respect
antigen
detect
enzymelink
immunosorb
assay
mice
immunis
denatur
viru
particl
surfac
project
protect
infect
mous
hepat
viru
strain
wherea
immunis
viru
membran
ribonucleoprotein
subcompon
fail
protect
mice
viru
challeng
mous
hepat
viru
mhv
member
coronavirida
group
virus
lipidcontain
envelop
positivestrand
virus
bud
endoplasm
reticular
membran
structur
polypeptid
number
mhv
strain
includ
strain
j
h
describ
consist
polypeptid
similar
size
composit
polypeptid
main
type
high
tool
wt
glycopolypeptid
compris
surfac
project
low
tool
wt
polypeptid
form
membran
protein
singl
polypeptid
mol
compris
ribonucleoprotein
np
sever
report
describ
separ
subvir
compon
mhv
coronavirus
disrupt
viru
particl
nonidet
triton
x
strain
mice
infect
mhv
develop
fulmin
hepat
although
numer
organ
also
infect
h
v
grown
confluent
secondari
u
e
e
b
r
n
c
fibroblast
monolay
infect
n
n
p
u
u
l
p
l
c
infecti
particl
per
ceil
n
follow
n
adsorpt
period
h
u
r
c
n
c
u
b
e
h
u
r
c
eagl
e
w
h
per
cent
foetal
calf
e
r
u
aliquot
viru
suspens
store
n
use
h
e
p
r
e
p
r
n
purifi
viru
particl
n
u
b
c
p
n
e
n
viru
purifi
c
describ
previous
viru
pellet
g
h
u
r
n
h
e
n
resuspend
ml
dulbecco
p
h
p
h
e
buffer
salin
pbsa
h
e
resuspend
viru
overlaid
linear
p
e
r
cent
ww
sucros
g
r
e
n
p
b
n
centrifug
hour
g
h
e
viru
peak
gml
collect
p
r
e
p
r
n
purifi
viru
part
icier
dialys
p
b
hour
c
n
h
e
n
r
u
p
e
w
h
per
cent
n
n
e
p
b
c
order
h
viru
c
p
n
e
n
avail
iodin
h
e
n
n
procedur
use
base
h
describ
b
greenwood
et
al
sucrosegratientpurifi
viru
particl
r
u
p
e
c
p
e
r
cent
n
n
e
p
p
b
n
layer
either
per
cent
ww
per
cent
ww
sucros
gradient
p
b
n
centrifug
hour
g
c
u
b
c
p
n
e
n
peak
locat
gml
per
cent
ww
sucros
gradient
n
n
gml
per
cent
ww
sucros
gradient
describ
previous
h
c
v
n
e
viru
n
viru
u
b
e
p
n
e
n
fraction
r
e
e
w
h
per
cent
sodium
dodecyl
sulphat
per
cent
e
r
c
p
e
h
n
l
minut
trace
b
r
p
h
e
n
l
blue
e
h
e
reduc
prepar
n
h
e
polypeptid
eleetrophores
h
r
u
g
h
per
cent
p
l
c
r
l
e
gel
describ
previous
electrophoresi
h
e
gel
e
x
r
u
e
n
slice
disc
n
r
c
v
e
e
r
n
e
immunis
procedur
week
old
r
n
mice
b
n
e
h
e
specificpathogenfre
spf
u
n
centr
group
mice
u
n
e
w
h
dilut
purifi
e
n
u
r
e
h
v
particl
p
r
e
p
r
n
titr
b
u
viru
subcompon
deriv
pbsa
particl
denatur
formalin
dilut
pbsa
day
c
antigen
suspend
equal
volum
freund
complet
adjuv
ml
volum
inject
intraperiton
mice
two
dose
day
interv
day
immunis
mice
challeng
intraperiton
ml
differ
titr
infecti
mttv
control
mice
challeng
pbsa
flatbottom
well
polystyren
microtitr
plate
dynatech
coat
dupiicatc
ml
amount
antigen
dilut
carbonatebicarbon
buffer
ph
incub
overnight
room
temperatur
incub
plate
ware
wash
time
phosphatebuff
salin
contain
per
cent
tween
per
cent
sodium
azid
pbst
shaken
dri
portion
ml
sara
dilut
pbst
ad
well
incub
hour
room
temperatur
addit
wash
pbst
ml
quantiti
rabbit
antimous
igg
antiserum
mile
laboratori
dilut
l
ad
left
hour
room
temperatur
plate
wash
time
pbst
wash
goat
antirabbit
igg
antiserum
label
alkalin
phosphatas
conjug
mile
laboratori
dilut
ad
ml
quantiti
room
temperatur
overnight
addit
wash
pbst
ml
phosphatasc
substrat
consist
per
cent
solut
pnitrophenylphosph
per
cent
wv
diethanolamin
buffer
ph
per
cent
sodium
azid
per
cent
ad
well
absorb
valu
read
minut
nm
flow
titertek
multiscan
photomet
purifi
h
v
particl
obtain
sucros
densiti
gradient
describ
previous
subvir
compon
obtain
b
centrifug
n
n
e
p
disrupt
h
v
particl
sucros
densiti
gradient
similar
w
h
describ
previous
h
e
p
r
e
p
r
n
hcv
subcompon
surfac
project
isol
per
cent
ww
sucros
e
n
gradient
gml
n
e
b
r
n
e
n
r
n
p
fraction
isol
per
cent
ww
sucros
gradient
gml
respect
p
u
r
subcompon
e
e
r
n
e
b
iodin
h
e
h
e
n
analys
polypeptid
p
l
c
r
l
e
get
fig
show
p
l
c
r
l
e
gel
iodin
polypeptid
n
n
e
r
u
p
e
particl
similar
obtain
previous
unlabel
label
h
v
polypeptid
polypeptid
e
n
mol
wt
call
v
g
p
v
p
v
g
p
v
p
vp
viru
p
l
p
e
p
e
vgp
viru
glycopolypeptid
p
l
p
e
p
e
e
n
mot
wt
observ
previous
resolv
although
present
b
u
k
e
b
high
b
c
k
g
r
u
n
radioact
similar
polypeptid
obtain
h
v
strain
polypeptidc
compris
surfac
project
e
b
r
n
e
r
n
p
shown
correspond
v
g
p
v
g
p
v
p
vp
respect
fig
e
polyacrylamid
gel
mhv
subcompon
prepar
isol
sucros
densiti
gradient
nonidet
disrupt
particl
gel
reveal
good
separ
structur
polypeptid
surfac
project
prepar
contain
vgp
fig
membran
prepar
vgp
vp
fig
b
rnp
prepar
vp
fig
c
evid
number
polyaerylamid
gel
contamin
subcompon
subcompon
although
consider
background
radioact
gel
iodin
subeompon
group
mice
immunis
one
number
dilut
sucrosegradientpurifi
inactiv
viru
particl
subcompon
prepar
correspond
dilut
miiv
subcompon
fraction
contain
compar
amount
antigen
determin
label
fig
mice
observ
day
period
mice
die
show
symptom
diseas
furthermor
sera
taken
inocul
day
inocul
antibodi
rise
postinocul
sera
measur
elisa
use
homolog
antigen
tabl
show
typic
elisa
absorb
valu
obtain
sera
taken
day
immunis
sera
ratio
postinocul
preinocul
serum
absorb
valu
antigen
serum
dilut
sigtfficantli
indic
specif
antibodi
develop
thu
viru
particl
subcompon
elicit
signific
antibodi
respons
elisa
use
heterolog
combin
subcompon
sera
produc
antigen
reaction
read
taken
nm
minut
b
antigen
dilut
c
sera
mice
given
dilut
viru
particl
viru
subeompon
obtain
day
immunis
sera
dilut
tabl
show
elisa
ratio
obtain
sera
anim
immunis
day
number
dilut
denatur
viru
particl
viru
subeompon
test
homolog
antigen
signific
antibodi
rise
measur
elisa
ratio
observ
sera
mice
inocul
denatur
viru
particl
although
mice
inocul
subcompon
fraction
antibodi
rise
detect
purifi
subvir
compon
dose
depend
eas
test
membran
r
n
p
compon
less
immunogen
mice
surfac
project
compon
even
repeat
immunis
dilut
denatur
viru
particl
subcompon
immunis
period
day
select
tabl
suitabl
produc
high
level
antibodi
immunis
mice
immunis
mice
h
j
itasoni
n
r
acnavgton
challeng
differ
titr
infecti
mhv
pbsa
tabl
mice
observ
daili
day
number
surviv
day
note
mice
immunis
denatur
viru
particl
mice
immunis
surfac
project
surviv
day
challeng
mhv
nonimmunis
mice
kill
day
viru
challeng
mhv
dilut
test
first
death
occur
day
howev
nonimmunis
mice
challeng
pbsa
show
sign
ill
mice
immunis
purifi
membran
r
n
p
fraction
protect
mhv
challeng
die
within
day
diseuss
paper
report
isol
purif
mhv
subvir
compon
shown
role
subcompon
protect
immnnis
mice
challeng
infecti
mhv
difficult
ensur
mice
immunis
differ
viru
subcompon
prepar
produc
compar
amount
antibodi
consider
variat
immunogeni
subeompon
highest
antibodi
rise
detect
elisa
direct
surfac
project
lower
antibodi
rise
observ
membran
rnp
suggest
immunogen
part
viru
antigen
associ
surfac
project
similar
result
obtain
previous
human
eoronavirus
porcin
coronaviru
transmiss
gastroenter
viru
tgev
shown
close
correl
protect
mice
infect
antibodi
rise
inactiv
viru
particl
surfac
project
fm
hermor
experi
report
show
rabbit
sow
inocul
whole
tgev
particl
surfac
project
may
protect
viru
challeng
stimul
neutralis
antibodi
similar
properti
observ
surfac
project
lipidcontain
envelop
rna
virus
result
mhv
membran
r
n
p
subcompon
suggest
although
antibodi
induc
subeompon
mice
antibodi
produc
rel
low
amount
deteet
protect
effect
infect
repeat
immunis
mice
membran
r
n
p
subeompon
lead
increas
amount
antibodi
protect
mhv
infect
thu
unlik
subeompon
protect
protect
miss
due
poor
immunogeni
compon
declin
antigen
subeompon
nonidet
treatment
dialysi
eentrifug
sucros
gradient
hasoni
unpublish
data
shown
virus
includ
herpesvirus
elisa
igg
antibodi
measur
postinocul
mous
sera
although
immunoglobulin
elass
may
import
role
protect
mice
infect
howev
day
immunis
igg
antibodi
common
antibodi
present
predomin
role
protect
infect
studi
progress
extend
experi
coronavirus
determin
antigen
structur
relationship
coronaviru
subcompon
